Market Overview:
The global Surgicel absorbable hemostat market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of trauma and surgery, rising awareness about surgical procedures, and technological advancements in the field of hemostasis. By type, the Surgicel absorbable hemostat market is segmented into particles, powder, and other segments. The particle segment is expected to account for the largest share of the global Surgicel absorbable hemostat market in 2018 owing to its high efficiency in stopping bleeding. By application, hospitals are expected to account for the largest share of the global Surgicel absorbable hemostat market in 2018 owing to their large patient population base and growing demand for surgical procedures.
Product Definition:
Surgicel Absorbable Hemostat is a surgical adhesive that is used to control bleeding. It is important because it helps to stop the bleeding and allows the surgery to be completed.
Particles:
Particles, it's usage and growth factor in Surgicel Absorbable Hemostat market: The global particles, it's usage and growth factor in surgical absorbable hemostats market size was valued at USD 6.5 billion in 2016. It is likely to expand at a CAGR of XX% over the forecast period.
Powder:
Powder is made up of highly absorbent polymers that are used to control bleeding by forming a physical barrier around the cut. It works like a plug and prevents blood from getting out of the body. Powder is available in different forms such as gauze, films, powders, and sponges among others. The type of powder used depends on the situation or condition being treated.
Application Insights:
Based on application, the global market is segmented into hospital, clinics and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to a high prevalence of chronic diseases such as cardiovascular diseases, cancer and diabetes that require regular medical monitoring and treatment at hospitals or clinics. As a result, demand for surgicelabs products used during surgeries is significantly increasing at present day owing to rising healthcare spending by governments across the globe.
The other application segment includes dental care centers, veterinary care facilities and research studies. In dental care centers & vet ¢â‚¬â„¢s offices/clinics.
Regional Analysis:
North America dominated the global market in 2017 owing to the increasing number of surgical procedures and rising prevalence of chronic diseases. The region is expected to maintain its dominance over the forecast period due to technological advancements, high healthcare expenditure, and presence of major players.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to an increase in medical tourism along with growing patient awareness regarding advanced surgeries & treatments. Moreover, a rise in government initiatives for improving healthcare infrastructure is also likely to drive regional growth over next eight years.
Growth Factors:
- Increasing incidence of trauma and accidents: The increasing incidence of trauma and accidents is one of the key growth drivers for the Surgicel Absorbable Hemostat market. Trauma is a leading cause of death worldwide, accounting for more than 5 million deaths each year.2. Growing demand for minimally invasive surgeries: Minimally invasive surgeries are gaining popularity due to their many benefits over traditional open surgeries, such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. This is driving the demand for Surgicel Absorbable Hemostat products in the surgical market.3. Rising geriatric population: The global geriatric population is growing at a rapid pace due to improvements in healthcare infrastructure and lifestyle changes among older people across the world. This is resulting in an increase in age-related diseases such as cancer, heart disease, stroke, Alzheimer’s disease etc., which are leading to an increase in surgical procedures performed on elderly patients.4 . Technological advancements: The development of new absorbable hemostats that offer better performance characteristics than existing products is helping to drive growth in this market segment5 . Growing awareness about hemostats: There has been a growing awareness about hemostats among surgeons over recent years owing to their advantages over traditional methods such as suturing or ligating vessels
Scope Of The Report
Report Attributes
Report Details
Report Title
Surgicel Absorbable Hemostat Market Research Report
By Type
Particles, Powder, Other
By Application
Hospital, Clinics, Other
By Companies
Johnson & Johnson, BD, Meril Life Sciences, Betatech, Cura Medical, Gelita Medical, Medprin Biotech, Altaylar Medical, Samyang Group, Baxter, B Braun, Hemostasis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Surgicel Absorbable Hemostat Market Report Segments:
The global Surgicel Absorbable Hemostat market is segmented on the basis of:
Types
Particles, Powder, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- BD
- Meril Life Sciences
- Betatech
- Cura Medical
- Gelita Medical
- Medprin Biotech
- Altaylar Medical
- Samyang Group
- Baxter
- B Braun
- Hemostasis
Highlights of The Surgicel Absorbable Hemostat Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Particles
- Powder
- Other
- By Application:
- Hospital
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Surgicel Absorbable Hemostat Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Surgicel Absorbable Hemostat is a medical device that helps stop bleeding by absorbing blood.
Some of the major players in the surgicel absorbable hemostat market are Johnson & Johnson, BD, Meril Life Sciences, Betatech, Cura Medical, Gelita Medical, Medprin Biotech, Altaylar Medical, Samyang Group, Baxter, B Braun, Hemostasis.
The surgicel absorbable hemostat market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Surgicel Absorbable Hemostat Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Surgicel Absorbable Hemostat Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Surgicel Absorbable Hemostat Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Surgicel Absorbable Hemostat Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Surgicel Absorbable Hemostat Market Size & Forecast, 2020-2028
4.5.1 Surgicel Absorbable Hemostat Market Size and Y-o-Y Growth
4.5.2 Surgicel Absorbable Hemostat Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Particles
5.2.2 Powder
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Surgicel Absorbable Hemostat Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Surgicel Absorbable Hemostat Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Particles
9.6.2 Powder
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Particles
10.6.2 Powder
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Particles
11.6.2 Powder
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Particles
12.6.2 Powder
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Particles
13.6.2 Powder
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Surgicel Absorbable Hemostat Market: Competitive Dashboard
14.2 Global Surgicel Absorbable Hemostat Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 BD
14.3.3 Meril Life Sciences
14.3.4 Betatech
14.3.5 Cura Medical
14.3.6 Gelita Medical
14.3.7 Medprin Biotech
14.3.8 Altaylar Medical
14.3.9 Samyang Group
14.3.10 Baxter
14.3.11 B Braun
14.3.12 Hemostasis
